Nilotinib Capsule
Product Images NDC 60505-3801

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 60505-3801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl-lbl-150mg-500s (Btl Lbl 150mg 500s)

Each capsule contains 150 mg of nilotinib. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed from 15°C to 30°C (59°F to 86°F). It is essential to dispense the capsules in a tight container. The usual dosage information can be found in the package insert. The medication guide should be provided to each patient separately by the pharmacist. It is recommended to take nilotinib capsules on an empty stomach and avoid food for at least 2 hours before and 1 hour after dosing. The medication is manufactured by Apotex Inc. for Apotex Corp.*

FDA Label Image

Btl-lbl-200mg-500s (Btl Lbl 200mg 500s)

Each capsule contains 200 mg of nilotinib and should be stored at a temperature between 20°C to 25°C (68°F to 77°F). Dispense the medication in a tight container. The usual dosage information can be found in the package insert. The capsules should be taken on an empty stomach, and food should be avoided for at least 2 hours before and 1 hour after taking a dose. The medication is manufactured for Apotex Corp. in Weston, Florida, by Apote Inc in Toronto, Ontario, Canada.*

FDA Label Image

Btl-lbl-50mg-120s (Btl Lbl 50mg 120s)

Each capsule contains 50 mg of nilotinib. Store between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). Dispense in a tight container. Usual dosage specified in the package insert. These 120 capsules of Nilotinib are for pharmacist dispensing. Take Nilotinib capsules on an empty stomach, avoiding food for at least 2 hours before and 1 hour after dosing. Manufactured by Apotex Inc in Toronto, Canada, for Apotex Corp in Weston, Florida.*

FDA Label Image

Fig-14-1 (Figure 14 1)

FDA Label Image

Fig-14-2 (Figure 14 2)

FDA Label Image

Inn-ctn-lbl-150mg-28s (Inn Ctn Lbl 150mg 28s)

FDA Label Image

Out-ctn-lbl-200mg-112s (Out Ctn Lbl 200mg 112s)

This is a drug information sheet for Nilotinib capsules, each pack contains 28 capsules. The instructions advise taking the capsules on an empty stomach, avoiding food for at least 2 hours before and 1 hour after. Pharmacist should dispense the enclosed Medication Guide to each patient. The manufacturer is APOTEX CORP.*

FDA Label Image

Chemical Structure Of Nilotinib (Tasigna 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.